Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Raloxifene therapy inhibits osteoclastogenesis during the alveolar healing process in rats

Full text
Author(s):
Luvizuto, Eloa R. [1] ; Dias, Sheila S. M. D. [1] ; Okamoto, Tetuo [2] ; Dornelles, Rita C. M. [3] ; Okamoto, Roberta [2]
Total Authors: 5
Affiliation:
[1] UNESP Univ Estadual Paulista, Aracatuba Dent Sch, Dept Surg & Integrated Clin, Jaboticabal - Brazil
[2] Univ Sagrado Coracao USC Bauru, Dept Res & Post Grad, Bauru, SP - Brazil
[3] UNESP Univ Estadual Paulista, Aracatuba Dent Sch, Dept Basic Sci, Jaboticabal - Brazil
Total Affiliations: 3
Document type: Journal article
Source: ARCHIVES OF ORAL BIOLOGY; v. 56, n. 10, p. 984-990, OCT 2011.
Web of Science Citations: 17
Abstract

Objective: To investigate the expression of OPG, RANKL and TRAP during alveolar healing process (7, 14, 21, 28 and 42 postoperative days) in ovariectomized rats treated with raloxifene or with oestrogen replacement therapy, using immunohistochemistry reaction approach. Materials and methods: Wistar female rats (10 weeks age) were submitted to ovariectomy surgery (OVX) or sham surgery. The female rats were divided in four groups: (1) sham; (2) OVX/O (ovariectomy and oil); (3) OVX/E2 (ovariectomy and oestrogen replacement); (4) OVX/RLX (ovariectomy and raloxifene therapy). Results: It was observed high amount of OPG immunolabelling with predominance at 14 and 21 postoperative days on sham and OVX/RLX groups, respectively. At 7 postoperative days, there was no difference between the groups for TRAP protein. Otherwise, to the other periods, it was observed greater expression of TRAP and RANKL protein on OVX/O group compared to sham, OVX/E2 and OVX/RLX groups. It was also observed a discrete TRAP immunolabelling at 28 and 42 postoperative days on OVX/RLX group. Conclusions: Oestrogen deficiency induces osteoclastogenesis in the alveolar healing process. Quantitative changes in the osteoclastic activity could be prevented through the raloxifene therapy. (C) 2011 Elsevier Ltd. All rights reserved. (AU)